Stephen J. Hill

Insider Reports History

Entity
Individual
Location
C/O Lyell Immunopharma, Inc., 400 East Jamie Court, Suite 301, South San Francisco, CA
Signature
/s/ Matthew Lang, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen J. Hill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Chief Operating Officer Common Stock 48.9K $112K $2.28 Feb 9, 2024 Direct
Lyell Immunopharma, Inc. Chief Operating Officer Stock Option (right to buy) 400K Feb 9, 2024 Direct

Insider Reports Filed by Stephen J. Hill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYEL Lyell Immunopharma, Inc. Feb 9, 2024 2 $0 4 Feb 13, 2024 Chief Operating Officer
LYEL Lyell Immunopharma, Inc. Nov 16, 2023 12 $0 4 Nov 20, 2023 Chief Technical Ops. Officer
LYEL Lyell Immunopharma, Inc. Feb 24, 2023 1 $0 4 Feb 28, 2023 Chief Technical Ops. Officer
LYEL Lyell Immunopharma, Inc. Mar 16, 2022 1 $0 4 Mar 18, 2022 Chief Technical Ops. Officer
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Chief Technical Ops. Officer